{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:01:14Z","timestamp":1778155274962,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T00:00:00Z","timestamp":1256860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s00467-009-1353-0","type":"journal-article","created":{"date-parts":[[2009,10,29]],"date-time":"2009-10-29T09:29:26Z","timestamp":1256808566000},"page":"553-556","source":"Crossref","is-referenced-by-count":13,"title":["A case of minimal change disease in a Fabry patient"],"prefix":"10.1007","volume":"25","author":[{"given":"Yuri A.","family":"Zarate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Hopkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,30]]},"reference":[{"key":"1353_CR1","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ (2008) Fabry\u2019s disease. Lancet 372:1427\u20131435","journal-title":"Lancet"},{"issue":"Suppl 2","key":"1353_CR2","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1097\/01.ASN.0000016683.73778.78","volume":"13","author":"M Branton","year":"2002","unstructured":"Branton M, Schiffmann R, Kopp JB (2002) Natural history and treatment of renal involvement in Fabry disease. J Am Soc Nephrol 13(Suppl 2):S139\u2013S143","journal-title":"J Am Soc Nephrol"},{"key":"1353_CR3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/08035250500275022","volume":"95","author":"U Ramaswami","year":"2006","unstructured":"Ramaswami U, Whybra C, Parini R, Pintos-Morell G, Mehta A, Sunder-Plassmann G, Widmer U, Beck M, FOS European Investigators (2006) Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey. Acta Paediatr 95:86\u201392","journal-title":"Acta Paediatr"},{"key":"1353_CR4","doi-asserted-by":"crossref","unstructured":"Ries M, Clarke JT, Whybra C, Timmons M, Robinson C, Schlaggar BL, Pastores G, Lien YH, Kampmann C, Brady RO, Beck M, Schiffmann R (2006) Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease. Pediatrics 118:924\u2013932","DOI":"10.1542\/peds.2005-2895"},{"key":"1353_CR5","doi-asserted-by":"crossref","unstructured":"Ries M, Gupta S, Moore DF, Sachdev V, Quirk JM, Murray GJ, Rosing DR, Robinson C, Schaefer E, Gal A, Dambrosia JM, Garman SC, Brady RO, Schiffmann R (2005) Pediatric Fabry disease. Pediatrics 115:e344\u2013e355","DOI":"10.1542\/peds.2004-1678"},{"key":"1353_CR6","doi-asserted-by":"crossref","unstructured":"Hopkin RJ, Bissler J, Banikazemi M, Clarke L, Eng CM, Germain DP, Lemay R, Tylki-Szymanska A, Wilcox WR (2008) Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry. Pediatr Res 64:550\u2013555","DOI":"10.1203\/PDR.0b013e318183f132"},{"key":"1353_CR7","doi-asserted-by":"crossref","unstructured":"Branton MH, Schiffmann R, Sabnis SG, Murray GJ, Quirk JM, Altarescu G, Goldfarb L, Brady RO, Balow JE, Austin Iii HA, Kopp JB (2002) Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) 81:122\u2013138","DOI":"10.1097\/00005792-200203000-00003"},{"key":"1353_CR8","doi-asserted-by":"crossref","unstructured":"Cybulla M, Schaefer E, Wendt S, Ling H, Krober SM, Hovelborn U, Schandelmaier S, Rohrbach R, Neumann HP (2005) Chronic renal failure and proteinuria in adulthood: Fabry disease predominantly affecting the kidneys. Am J Kidney Dis 45:e82\u2013e89","DOI":"10.1053\/j.ajkd.2005.01.036"},{"key":"1353_CR9","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/ndt\/gfm848","volume":"23","author":"A Ortiz","year":"2008","unstructured":"Ortiz A, Oliveira JP, Waldek S, Warnock DG, Cianciaruso B, Wanner C (2008) Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy. Nephrol Dial Transplant 23:1600\u20131607","journal-title":"Nephrol Dial Transplant"},{"key":"1353_CR10","first-page":"1303","volume":"36","author":"A Yoshida","year":"1994","unstructured":"Yoshida A, Morozumi K, Takeda A, Koyama K, Oikawa T (1994) Fabry-like laminated myelin body associated with IgA nephropathy. Nippon Jinzo Gakkai Shi 36:1303\u20131307","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"1353_CR11","unstructured":"Kawamura O, Sakuraba H, Itoh K, Suzuki Y, Doi M, Kuwabara H, Oshima S, Abe S, Warabi H, Yoshizawa N (1997) Subclinical Fabry\u2019s disease occurring in the context of IgA nephropathy. Clin Nephrol 47:71\u201375"},{"key":"1353_CR12","unstructured":"Pisani A, Sessa A, Sabbatini M, Andreucci MV, Fusco C, Balletta M, Cianciaruso B (2005) Fabry nephropathy in a female with superposed IgA glomerulonephritis. G Ital Nefrol 22:385\u2013389"},{"key":"1353_CR13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000063287","volume":"92","author":"K Shimazu","year":"2002","unstructured":"Shimazu K, Tomiyoshi Y, Aoki S, Sakemi T, Sugihara H (2002) Crescentic glomerulonephritis in a patient with heterozygous Fabry\u2019s disease. Nephron 92:456\u2013458","journal-title":"Nephron"},{"key":"1353_CR14","first-page":"73","volume":"55","author":"HK Singh","year":"2001","unstructured":"Singh HK, Nickeleit V, Kriegsmann J, Harris AA, Jennette JC, Mihatsch MJ (2001) Coexistence of Fabry\u2019s disease and necrotizing and crescentic glomerulonephritis. Clin Nephrol 55:73\u201379","journal-title":"Clin Nephrol"},{"issue":"Suppl 2","key":"1353_CR15","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/01.ASN.0000016684.07368.75","volume":"13","author":"J Alroy","year":"2002","unstructured":"Alroy J, Sabnis S, Kopp JB (2002) Renal pathology in Fabry disease. J Am Soc Nephrol 13(Suppl 2):S134\u2013S138","journal-title":"J Am Soc Nephrol"},{"key":"1353_CR16","doi-asserted-by":"crossref","unstructured":"Thurberg BL, Rennke H, Colvin RB, Dikman S, Gordon RE, Collins AB, Desnick RJ, O'Callaghan M (2002) Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int 62:1933\u20131946","DOI":"10.1046\/j.1523-1755.2002.00675.x"},{"key":"1353_CR17","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1681\/ASN.2006121400","volume":"18","author":"H Tahir","year":"2007","unstructured":"Tahir H, Jackson LL, Warnock DG (2007) Antiproteinuric therapy and Fabry nephropathy: sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-beta. J Am Soc Nephrol 18:2609\u20132617","journal-title":"J Am Soc Nephrol"},{"key":"1353_CR18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/modpathol.3800634","volume":"19","author":"EG Fischer","year":"2006","unstructured":"Fischer EG, Moore MJ, Lager DJ (2006) Fabry disease: a morphologic study of 11 cases. Mod Pathol 19:1295\u20131301","journal-title":"Mod Pathol"},{"key":"1353_CR19","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/01.smj.0000243183.87381.c2","volume":"99","author":"TC Saha","year":"2006","unstructured":"Saha TC, Singh H (2006) Minimal change disease: a review. South Med J 99:1264\u20131270","journal-title":"South Med J"},{"key":"1353_CR20","first-page":"1977","volume":"98","author":"I Anochie","year":"2006","unstructured":"Anochie I, Eke F, Okpere A (2006) Childhood nephrotic syndrome: change in pattern and response to steroids. J Natl Med Assoc 98:1977\u20131981","journal-title":"J Natl Med Assoc"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-009-1353-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-009-1353-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-009-1353-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:45:13Z","timestamp":1559090713000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-009-1353-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,30]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["1353"],"URL":"https:\/\/doi.org\/10.1007\/s00467-009-1353-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,30]]}}}